MATUCCI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 2.931
EU - Europa 2.775
AS - Asia 2.205
SA - Sud America 244
AF - Africa 40
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.202
Nazione #
US - Stati Uniti d'America 2.860
RU - Federazione Russa 1.035
SG - Singapore 950
GB - Regno Unito 709
CN - Cina 654
IT - Italia 219
BR - Brasile 201
VN - Vietnam 199
HK - Hong Kong 173
SE - Svezia 157
DE - Germania 142
FR - Francia 132
FI - Finlandia 124
IE - Irlanda 111
KR - Corea 70
CA - Canada 49
UA - Ucraina 42
IN - India 35
PL - Polonia 22
BE - Belgio 19
ES - Italia 19
TR - Turchia 18
JP - Giappone 16
MX - Messico 15
ID - Indonesia 14
NG - Nigeria 14
ZA - Sudafrica 13
AR - Argentina 12
EC - Ecuador 11
BD - Bangladesh 9
IQ - Iraq 8
PK - Pakistan 8
AT - Austria 7
NL - Olanda 7
PH - Filippine 7
IL - Israele 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
CL - Cile 5
JO - Giordania 5
UZ - Uzbekistan 5
VE - Venezuela 5
CO - Colombia 4
KE - Kenya 4
LV - Lettonia 4
CH - Svizzera 3
EG - Egitto 3
HU - Ungheria 3
LT - Lituania 3
PY - Paraguay 3
SA - Arabia Saudita 3
BG - Bulgaria 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
KG - Kirghizistan 1
LU - Lussemburgo 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
TL - Timor Orientale 1
Totale 8.202
Città #
Southend 636
Singapore 498
Jacksonville 357
Moscow 338
Chandler 293
San Jose 283
Ashburn 279
Dallas 186
Hong Kong 171
Woodbridge 161
Ann Arbor 145
Dublin 110
Houston 107
Beijing 102
Verona 85
The Dalles 84
Los Angeles 65
Ho Chi Minh City 61
New York 59
Nanjing 55
Hanoi 46
Lawrence 42
Princeton 42
Wilmington 40
Munich 39
Jinan 35
Boardman 31
Helsinki 30
Seattle 29
Tianjin 28
Buffalo 26
Sindelfingen 25
Hebei 24
Seoul 23
Shenyang 23
Da Nang 22
Milan 22
Changsha 21
Council Bluffs 21
Nanchang 21
Orem 20
São Paulo 20
Warsaw 19
Brussels 18
Hangzhou 18
Montreal 18
Zhengzhou 18
Santa Clara 17
Taizhou 17
Chicago 16
Haikou 16
Chennai 15
Ningbo 15
Redondo Beach 15
Tokyo 15
Abuja 14
Cambridge 14
Denver 14
Elora 14
Turku 14
Jiaxing 13
Columbus 12
Frankfurt am Main 11
San Francisco 11
Taiyuan 11
Johannesburg 10
Haiphong 9
Toronto 9
Cagliari 8
London 8
Poplar 8
Brooklyn 7
Clearwater 7
Guangzhou 7
Mexico City 7
Atlanta 6
Bologna 6
City of London 6
Fuzhou 6
Lanzhou 6
Norwalk 6
Phoenix 6
Quito 6
Redmond 6
Amman 5
Amsterdam 5
Ankara 5
Jakarta 5
Madrid 5
Querétaro 5
Rome 5
Stockholm 5
Tashkent 5
Arco 4
Baku 4
Belo Horizonte 4
Curitiba 4
Dongguan 4
Falkenstein 4
Lahore 4
Totale 5.257
Nome #
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 263
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 258
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 243
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 237
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 236
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 229
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 228
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 223
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 223
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 222
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 217
Presence and role of HLA-C in HIV-1 infection 203
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 203
Temperature-dependent decay of wheat germ agglutinin activity and its implications for food processing and analysis 201
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 201
Studio di immunogeni per l'induzione di anticorpi neutralizzati ad ampio spettro contro il virus dell'immunodeficienza umana (HIV-1) 196
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 194
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 185
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response 185
Induction of HIV-1 neutralizing antibodies by fusion complexes 180
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 176
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 175
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 174
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 173
Studies on the joint cytotoxicity of wheat germ agglutinin and monensin 172
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 170
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 168
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 166
HLA-C increases HIV-1 infectivity and is associated with gp120 157
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 151
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 146
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 145
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 145
Induction of human immunodeficiency virus (HIV) broad spectrum neutralizing antibodies with fusion complexes. 138
Changes in the Adaptive Cellular Repertoire after Infection with Different SARS-CoV-2 VOCs in a Cohort of Vaccinated Healthcare Workers 135
Presence and Role of HLA-C in HIV-1 Infection 127
Fusion complexes as broad spectrum anti-HIV vaccine 120
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly 111
Studio di nuovi immunogeni per l'induzione di anticorpi neutralizzanti ad ampio spettro contro il virus dell'immunodeficienza umana (HIV-1) 107
Use of gp120-CD4-coreceptor fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 105
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 104
Induction of HIV neutralizing antibodies using fusion complexes and a CD4-independent env 100
HLA-C increase fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 99
Study of the optimal conditions for obtaining fusion complexes to be used as broad spectrum anti HIV-1 vaccine 99
Immune signature in vaccinated versus non-vaccinated aged people with COVID-19 pneumonia 94
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 90
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 80
HLA class I increases the efficiency of fusion between the HIV-1 envelope and the target cell membrane and is parte of the fusion complex between the gp120/gp41 and the cellular receptors. 78
Tezepelumab in patients with allergic and eosinophilic asthma 50
HLA-C increases HIV-1 infectivity 44
Multidisciplinary Decision-Making—ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study) 43
null 33
null 32
Totale 8.234
Categoria #
all - tutte 25.724
article - articoli 12.026
book - libri 0
conference - conferenze 12.862
curatela - curatele 0
other - altro 836
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 10 44 5
2021/2022361 42 107 4 30 5 6 3 22 12 9 32 89
2022/2023843 69 101 76 130 86 193 3 55 91 8 20 11
2023/2024376 13 37 24 47 46 56 11 25 3 30 44 40
2024/20251.135 39 71 18 133 44 37 83 46 209 107 90 258
2025/20263.429 255 127 230 581 951 304 352 173 248 208 0 0
Totale 8.234